Magnitude Biosciences is a specialist CRO offering whole-organism high-throughput phenotypic screening services for early drug discovery.
Magnitude Biosciences has raised $1.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2026.
Magnitude Biosciences's investors include Northstar Ventures, Innovate UK, Finance Durham Fund, Future Fund, North East Fund.
Magnitude Biosciences is headquartered in Durham, United Kingdom.
Magnitude Biosciences is a specialist CRO offering whole-organism high-throughput phenotypic screening services for early drug discovery.
Magnitude Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnitude Biosciences — Funding & Investors." VCBacked, September 15, 2026, https://www.vcbacked.co/company/magnitude-biosciences. Accessed October 19, 2026.
VCBacked. (2026). Magnitude Biosciences — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/magnitude-biosciences
{{cite web |title=Magnitude Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/magnitude-biosciences |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated